Genome-wide DNA methylation profiling of recurrent and non-recurrent chordomas

References

• Walcott BP, Nahed BV, Mohyeldin A, Coumans JV, Kahle KT, Ferreira MJ. Chordoma: current concepts, management, and future directions. Lancet Oncol 2012; 13:e69-76; PMID:22300861; http://dx.doi.org/10.1016/S1470-2045(11)70337-0
   PubMed Web of Science ®Google Scholar
• Williams BJ, Raper DM, Godbout E, Bourne TD, Prevedello DM, Kassam AB, Park DM. Diagnosis and treatment of chordoma. J Natl Compr Canc Netw 2013; 11:726-31; PMID:23744869
   PubMed Web of Science ®Google Scholar
• Yakkioui Y, van Overbeeke JJ, Santegoeds R, van Engeland M, Temel Y. Chordoma: the entity. Biochim Biophys Acta 2014; 1846:655-69; PMID:25193090
   PubMed Web of Science ®Google Scholar
• Vujovic S, Henderson S, Presneau N, Odell E, Jacques TS, Tirabosco R, Boshoff C, Flanagan AM. Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J Pathol 2006; 209:157-65; PMID:16538613; http://dx.doi.org/10.1002/path.1969
   PubMed Web of Science ®Google Scholar
• Presneau N, Shalaby A, Ye H, Pillay N, Halai D, Idowu B, Tirabosco R, Whitwell D, Jacques TS, Kindblom LG, et al. Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study. J Pathol 2011; 223:327-35; PMID:21171078; http://dx.doi.org/10.1002/path.2816
   PubMed Web of Science ®Google Scholar
• Heyn H, Esteller M. DNA methylation profiling in the clinic: applications and challenges. Nat Rev Genet 2012; 13:679-92; PMID:22945394; http://dx.doi.org/10.1038/nrg3270
   PubMed Web of Science ®Google Scholar
• Richter AM, Pfeifer GP, Dammann RH. The RASSF proteins in cancer; from epigenetic silencing to functional characterization. Biochim Biophys Acta 2009; 1796:114-28; PMID:19344752
   PubMed Web of Science ®Google Scholar
• Stirzaker C, Taberlay PC, Statham AL, Clark SJ. Mining cancer methylomes: prospects and challenges. Trends Genet 2014; 30:75-84; PMID:24368016; http://dx.doi.org/10.1016/j.tig.2013.11.004
   PubMed Web of Science ®Google Scholar
• Scheil S, Brüderlein S, Liehr T, Starke H, Herms J, Schulte M, Möller P. Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1. Genes Chromosomes Cancer 2001; 32:203-11; PMID:11579460; http://dx.doi.org/10.1002/gcc.1184
   PubMed Web of Science ®Google Scholar
• Rinner B, Froehlich EV, Buerger K, Knausz H, Lohberger B, Scheipl S, Fischer C, Leithner A, Guelly C, Trajanoski S, Szuhai K, Liegl B. Establishment and detailed functional and molecular genetic characterisation of a novel sacral chordoma cell line, MUG-Chor1. Int J Oncol 2012; 40:443-51; PMID:22002331
   PubMed Web of Science ®Google Scholar
• Siu IM, Salmasi V, Orr BA, Zhao Q, Binder ZA, Tran C, Ishii M, Riggins GJ, Hann CL, Gallia GL. Establishment and characterization of a primary human chordoma xenograft model. J Neurosurg 2012;116:801-9; PMID:22283186; http://dx.doi.org/10.3171/2011.12.JNS111123
   PubMed Web of Science ®Google Scholar
• Trucco MM, Awad O, Wilky BA, Goldstein SD, Huang R, Walker RL, Shah P, Katuri V, Gul N, Zhu YJ, et al. A novel chordoma xenograft allows in vivo drug testing and reveals the importance of NF-κB signaling in chordoma biology. PLoS One 2013; 8:e79950; PMID:24223206; http://dx.doi.org/10.1371/journal.pone.0079950
   PubMed Web of Science ®Google Scholar
• Karikari IO, Gilchrist CL, Jing L, Alcorta DA, Chen J, Richardson WJ, Gabr MA, Bell RD, Kelley MJ, Bagley CA, et al. Molecular characterization of chordoma xenografts generated from a novel primary chordoma cell source and two chordoma cell lines. J Neurosurg Spine 2014; 21:386-93; PMID:24905390; http://dx.doi.org/10.3171/2014.4.SPINE13262
   PubMed Web of Science ®Google Scholar
• Bozzi F, Manenti G, Conca E, Stacchiotti S, Messina A, Dagrada G, Gronchi A, Panizza P, Pierotti MA, Tamborini E, Pilotti S. Development of transplantable human chordoma xenograft for preclinical assessment of novel therapeutic strategies. Neuro Oncol 2014; 16:72-80; PMID:24366975; http://dx.doi.org/10.1093/neuonc/not152
   PubMed Web of Science ®Google Scholar
• Ahuja N, Easwaran H, Baylin SB. Harnessing the potential of epigenetic therapy to target solid tumors. J Clin Invest 2014; 124:56-63; PMID:24382390; http://dx.doi.org/10.1172/JCI69736
   PubMed Web of Science ®Google Scholar
• Heyn H, Méndez-González J, Esteller M. Epigenetic profiling joins personalized cancer medicine. Expert Rev Mol Diagn 2013;13:473-9; PMID:23782254; http://dx.doi.org/10.1586/erm.13.36
   PubMed Web of Science ®Google Scholar
• Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 2000; 25:315-9; PMID:10888881; http://dx.doi.org/10.1038/77083
   PubMed Web of Science ®Google Scholar
• Wales MM, Biel MA, el Deiry W, Nelkin BD, Issa JP, Cavenee WK, Kuerbitz SJ, Baylin SB. p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nat Med 1995; 1:570-7; PMID:7585125; http://dx.doi.org/10.1038/nm0695-570
   PubMed Web of Science ®Google Scholar
• Choi KS, Cohn MJ, Harfe BD. Identification of nucleus pulposus precursor cells and notochordal remnants in the mouse: implications for disk degeneration and chordoma formation. Dev Dyn 2008; 237:3953-8; PMID:19035356; http://dx.doi.org/10.1002/dvdy.21805
   PubMed Web of Science ®Google Scholar
• Rinner B, Weinhaeusel A, Lohberger B, Froehlich EV, Pulverer W, Fischer C, Meditz K, Scheipl S, Trajanoski S, Guelly C, Leithner A, Liegl B. Chordoma characterization of significant changes of the DNA methylation pattern. PLoS One 2013; 8:e56609; PMID:23533570; http://dx.doi.org/10.1371/journal.pone.0056609
   PubMed Web of Science ®Google Scholar
• Sabova L, Kretova M, Luciakova K. New insights into the role of NF1 in cancer. Neoplasma 2013; 60:233-9; PMID:23373991; http://dx.doi.org/10.4149/neo_2013_031
   PubMed Web of Science ®Google Scholar
• Lin CH, Ji T, Chen CF, Hoang BH. Wnt signaling in osteosarcoma. Adv Exp Med Biol 2014; 804:33-45; PMID:24924167; http://dx.doi.org/10.1007/978-3-319-04843-7_2
   PubMed Web of Science ®Google Scholar
• Medves S, Duhoux FP, Ferrant A, Toffalini F, Ameye G, Libouton JM, Poirel HA, Demoulin JB. KANK1, a candidate tumor suppressor gene, is fused to PDGFRB in an imatinib-responsive myeloid neoplasm with severe thrombocythemia. Leukemia 2010; 24:1052-5; PMID:20164854; http://dx.doi.org/10.1038/leu.2010.13
   PubMed Web of Science ®Google Scholar
• Northcott PA, Korshunov A, Witt H, Hielscher T, Eberhart CG, Mack S, Bouffet E, Clifford SC, Hawkins CE, French P, et al. Medulloblastoma comprises four distinct molecular variants. J Clin Oncol 2011; 29:1408-14; PMID:20823417; http://dx.doi.org/10.1200/JCO.2009.27.4324
   PubMed Web of Science ®Google Scholar
• Devarajan A, Shih D, Reddy ST. Inflammation, infection, cancer and all that…the role of paraoxonases. Adv Exp Med Biol 2014; 824:33-41; PMID:25038992; http://dx.doi.org/10.1007/978-3-319-07320-0_5
   PubMed Web of Science ®Google Scholar
• Gharanei S, Brini AT, Vaiyapuri S, Alholle A, Dallol A, Arrigoni E, Kishida T, Hiruma T, Avigad S, Grimer R, et al. RASSF2 methylation is a strong prognostic marker in younger age patients with Ewing sarcoma. Epigenetics 2013; 8:893-8; PMID:23887284; http://dx.doi.org/10.4161/epi.25617
   PubMed Web of Science ®Google Scholar
• Alholle A, Brini AT, Gharanei S, Vaiyapuri S, Arrigoni E, Dallol A, Gentle D, Kishida T, Hiruma T, Avigad S, et al. Functional epigenetic approach identifies frequently methylated genes in Ewing sarcoma. Epigenetics 2013; 8:1198-204; PMID:24005033; http://dx.doi.org/10.4161/epi.26266
   PubMed Web of Science ®Google Scholar
• Assenov Y, Müller F, Lutsik P, Walter J, Lengauer T, Bock C. Comprehensive analysis of DNA methylation data with RnBeads. Nat Methods 2014; 11:1138-40; PMID: 25262207
   PubMed Web of Science ®Google Scholar
• Teschendorff AE, Marabita F, Lechner M, Bartlett T, Tegner J, Gomez-Cabrero D, Beck S. A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data. Bioinformatics 2013; 29:189-96; PMID:23175756; http://dx.doi.org/10.1093/bioinformatics/bts680
   PubMed Web of Science ®Google Scholar